These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 20648412)

  • 1. Primary aldosteronism and diabetes mellitus.
    Steichen O
    Horm Metab Res; 2010 Sep; 42(10):758-9; author reply 760. PubMed ID: 20648412
    [No Abstract]   [Full Text] [Related]  

  • 2. Is primary aldosteronism associated with diabetes mellitus? Results of the German Conn's Registry.
    Reincke M; Meisinger C; Holle R; Quinkler M; Hahner S; Beuschlein F; Bidlingmaier M; Seissler J; Endres S;
    Horm Metab Res; 2010 Jun; 42(6):435-9. PubMed ID: 20119885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diabetes mellitus related common medical disorders : recent progress in diagnosis and treatment. Topics: I. Pathophysiology, diagnosis and treatment: 3. Primary aldosteronism, resistant hypertension and diabetes mellitus].
    Shibata H; Itoh H
    Nihon Naika Gakkai Zasshi; 2013 Apr; 102(4):850-5. PubMed ID: 23772497
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prehypertension risk factors in children and adolescents with type 1 diabetes].
    Pietrzak I; Szadkowska A; Czerniawska E; Mianowska B; Bodalska-Lipińska J; Bodalski J
    Przegl Lek; 2006; 63 Suppl 3():111-4. PubMed ID: 16898504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolongation of the QT interval in primary aldosteronism.
    Matsumura K; Fujii K; Kansui Y; Arima H; Iida M
    Clin Exp Pharmacol Physiol; 2005; 32(1-2):66-9. PubMed ID: 15730437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and biochemical characteristics of normotensive patients with primary aldosteronism: a comparison with hypertensive cases.
    Médeau V; Moreau F; Trinquart L; Clemessy M; Wémeau JL; Vantyghem MC; Plouin PF; Reznik Y
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):20-8. PubMed ID: 18284637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.
    Giacchetti G; Ronconi V; Turchi F; Agostinelli L; Mantero F; Rilli S; Boscaro M
    J Hypertens; 2007 Jan; 25(1):177-86. PubMed ID: 17143190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of estimated insulin resistance and glucose intolerance to essential hypertension.
    Eriksson KF; Lindgärde F
    J Intern Med Suppl; 1991; 735():75-83. PubMed ID: 2043225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldosteronism and hypertension.
    Calhoun DA
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1039-45. PubMed ID: 17699324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment.
    Novello M; Catena C; Nadalini E; Colussi GL; Baroselli S; Chiuch A; Lapenna R; Bazzocchi M; Sechi LA
    J Hypertens; 2007 Jul; 25(7):1443-50. PubMed ID: 17563567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of antihypertensive therapy and blood pressure control on left ventricular geometry and function in subjects with type II diabetes: The Augsburg Diabetes Family Study.
    Kuch B; von Scheidt W; Peter W; Heier M; Wichmann HE; Meisinger C
    J Hum Hypertens; 2006 Oct; 20(10):757-64. PubMed ID: 16826194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular and systemic factors associated with diabetes mellitus in the adult population in rural and urban China. The Beijing Eye Study.
    Xu L; Xie XW; Wang YX; Jonas JB
    Eye (Lond); 2009 Mar; 23(3):676-82. PubMed ID: 18259206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased gain in baroreceptor-heart rate reflex in patients with primary aldosteronism.
    Munakata M; Aihara A; Imai Y; Omata K; Abe K; Yoshinaga K
    J Hypertens; 1995 Dec; 13(12 Pt 2):1648-53. PubMed ID: 8903626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular outcomes in patients with primary aldosteronism after treatment.
    Catena C; Colussi G; Nadalini E; Chiuch A; Baroselli S; Lapenna R; Sechi LA
    Arch Intern Med; 2008 Jan; 168(1):80-5. PubMed ID: 18195199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary aldosteronism in diabetic subjects with resistant hypertension.
    Umpierrez GE; Cantey P; Smiley D; Palacio A; Temponi D; Luster K; Chapman A
    Diabetes Care; 2007 Jul; 30(7):1699-703. PubMed ID: 17429062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes mellitus in an urban Palestinian population: prevalence and associated factors.
    Abdul-Rahim HF; Husseini A; Giacaman R; Jervell J; Bjertness E
    East Mediterr Health J; 2001; 7(1-2):67-78. PubMed ID: 12596954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Target organ damage in hyperaldosteronism versus essential hypertension--the Beer Sheba experience].
    Wolak T; Hazkani I; Friger M; Paran E
    Harefuah; 2010 Mar; 149(3):161-5, 194. PubMed ID: 20684167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of dysglycemia, body mass index, and waist-to-hip ratio on the prevalence of systemic hypertension in a lean Chinese population.
    Lin S; Cheng TO; Liu X; Mai J; Rao X; Gao X; Deng H; Shi M
    Am J Cardiol; 2006 Mar; 97(6):839-42. PubMed ID: 16516586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal glucose tolerance and blood pressure in Khon Kaen.
    Bhuripanyo K; Laopaiboon M; Bhuripanyo P; Kusalertjariya S; Khumsuk K
    J Med Assoc Thai; 1992 Sep; 75(9):529-35. PubMed ID: 1304023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectral characteristics of heart rate and blood pressure variability in primary aldosteronism.
    Veglio F; Melchio R; Rabbia F; Molino P; Martini G; Chiandussi L
    Am J Hypertens; 1995 May; 8(5 Pt 1):479-86. PubMed ID: 7662224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.